Verition Fund Management’s Evommune EVMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-43,936
Closed -$584K – 2443
2026
Q2
$584K Sell
43,936
-506,055
-92% -$11.8M ﹤0.01% 1598
2026
Q1
$12.6M Sell
549,991
-15,223
-3% -$344K 0.08% 248
2025
Q4
$9.7M Buy
+565,214
New +$10.6M 0.04% 481

Other funds holding EVMN

Verition Fund Management's EVMN Position: Q3 2026 in Review

Verition Fund Management sold out of Evommune (EVMN) in Q3 2026, closing a stake of 43,936 shares — an estimated $584K sold.

Verition Fund Management first reported a position in EVMN in Q4 2025 and held it in 3 quarters. The position peaked at $12.6M in Q1 2026. 104 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • Verition Fund Management reported no remaining Evommune position as of Q3 2026 after selling out during the quarter.
  • Verition Fund Management sold 43,936 Evommune shares in Q3 2026, an estimated $584K.
  • Verition Fund Management first reported a position in Evommune in Q4 2025 and held it in 3 quarters.
  • Verition Fund Management's Evommune position peaked at $12.6M in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Evommune as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.